What Happens If I Inject Wegovy Into a Stretch Mark?

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Injecting semaglutide into stretch marks carries specific risks that differ from standard injection into healthy subcutaneous tissue. Understanding proper injection technique protects your safety and treatment effectiveness while using compounded semaglutide from licensed pharmacies.

Why Stretch Marks Affect Semaglutide Injection Safety

Stretch marks form when collagen and elastin fibers in the middle skin layer rupture and heal irregularly, creating a zone of altered tissue structure. This scarred tissue has reduced blood flow and different absorption characteristics compared to undamaged fat tissue. When you inject semaglutide into a stretch mark, the medication may absorb unevenly or pool in unpredictable patterns, potentially reducing bioavailability and creating localized concentration spikes.

The skin barrier above a stretch mark remains intact, but the subcutaneous architecture below is compromised. Semaglutide requires consistent, predictable absorption into the bloodstream to maintain stable drug levels across your dosing week. Injecting directly into scarred zones introduces variables that make dose response unreliable, which is why medical guidance recommends avoiding these areas entirely.

Additionally, stretch mark tissue often has reduced nerve sensation, making it harder to detect if you inadvertently inject too deeply or trigger an inflammatory response. This sensory gap increases the risk of accidental intramuscular injection, which is not the intended route for subcutaneous semaglutide therapy.

Proper Subcutaneous Injection Technique for Semaglutide

Standard semaglutide injections target the fatty tissue layer directly beneath the skin (the subcutaneous or hypodermis layer), typically in the abdomen, thigh, or upper arm. This tissue type has consistent blood perfusion and predictable drug absorption kinetics established in clinical trials. Injecting at a 45- to 90-degree angle into healthy fat—approximately one-quarter to one-half inch deep—delivers the medication to the intended depot.

Before each injection, identify healthy skin and underlying tissue free of scars, stretch marks, bruises, or areas of inflammation. Rotate your injection sites in a systematic pattern to prevent lipohypertrophy (fat tissue thickening) and lipoatrophy (fat tissue loss), both of which can develop if you repeatedly inject the same location. PlexusDx recommends spacing injections at least one finger-width apart and avoiding the same site for at least two weeks.

Never inject if you have active skin infection, redness, or warmth at a potential site. If you are uncertain whether a mark qualifies as a stretch mark or scar, consult your prescribing physician before that injection. Many patients benefit from marking safe injection zones on their body with a washable pen to prevent accidental overlap.

How Scar Tissue Changes Medication Absorption

Mature stretch marks contain fibrous, collagen-rich tissue that resists fluid diffusion compared to native fat. Research shows that drug absorption from scarred subcutaneous tissue is 15–40% slower and more erratic than absorption from healthy tissue, depending on scar maturity and depth. This delay can prolong the time semaglutide reaches therapeutic levels in your bloodstream and increase the risk of subtherapeutic dosing.

Semaglutide acts as a glucagon-like peptide-1 receptor agonist, reducing hunger signals and improving blood glucose control through a dose-dependent mechanism. If your medication pools in scar tissue rather than absorbing steadily, you may experience unpredictable appetite suppression, variable blood sugar effects, or delayed nausea onset. This inconsistency makes it impossible for you and your provider to accurately gauge whether your current dose is working or whether you need adjustment.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Best Practices for Avoiding Stretch Marks During Semaglutide Therapy

Develop a rotation map for your injections using at least six distinct sites across your abdomen, thighs, and upper arms. Document each injection date and location in a calendar, app, or physical journal to ensure you never repeat a site sooner than every 14 days. This disciplined approach eliminates the temptation to inject into stretch marks out of convenience and protects against tissue damage that could disqualify future injection sites.

After weight loss on semaglutide, existing stretch marks do not vanish, but new stretch marks are less likely to form because your skin is adapting to gradual volume loss rather than rapid expansion. Maintaining consistent hydration and applying a broad-spectrum sunscreen to treated skin can improve collagen remodeling and reduce the appearance of stretch marks over time, though this is a cosmetic consideration separate from injection safety.

If you develop significant bruising, swelling, or skin thickening at any injection site, stop injecting in that area and alert your prescribing provider. PlexusDx compounded semaglutide is dispensed from licensed 503A pharmacies with detailed patient instructions; review these materials before your first injection and contact PlexusDx support if injection-site reactions occur.

PlexusDx Semaglutide Injection and Your Treatment Plan

PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with a flat monthly fee regardless of dose adjustment. Your dose may need to go up as your body adapts, but your price won't increase, removing cost barriers to finding your optimal therapeutic level. All PlexusDx medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical quality and consistency across batches.

When you begin semaglutide with PlexusDx, you receive comprehensive guidance on injection technique, site rotation, and storage. HSA and FSA funds are eligible for payment, and no insurance or membership fees apply. After your first month of treatment, you can add the Precision Peptide Genetic Test ($298) to identify how your unique GIPR variants influence your response—enabling your provider to personalize your therapy further and optimize outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What happens if I accidentally inject semaglutide directly into a stretch mark?

If you inject into a stretch mark, the medication may absorb irregularly and achieve lower peak blood levels than intended, potentially reducing appetite suppression and metabolic benefits for that dose cycle. One accidental injection into a stretch mark is unlikely to cause serious harm, but repeating the error could undermine your treatment consistency. Contact PlexusDx support or your prescribing provider if this occurs to confirm your next dose timing.

Can semaglutide injections cause new stretch marks to form?

Semaglutide itself does not cause stretch marks; however, rapid weight loss can increase the risk of stretch marks if skin elasticity is compromised by dehydration or genetic predisposition. Semaglutide typically produces gradual weight loss over weeks and months, which allows skin to remodel and reduces this risk. Staying hydrated and using adequate sunscreen during weight loss therapy supports skin health.

How much does PlexusDx compounded semaglutide cost per month?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with a flat monthly price regardless of dose level. Your dose may need to go up, but your price won't. HSA and FSA funds are eligible, and there are no insurance requirements or membership fees.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes, the Precision Peptide Genetic Test from PlexusDx analyzes 14 peptide-signaling pathways and 49 peptides, including key GLP1R variants (rs6923761) that influence semaglutide response. This $298 test after your first month of treatment provides personalized insights to help your provider optimize your therapy.

What is the difference between PlexusDx semaglutide and brand-name Ozempic or Wegovy?

PlexusDx semaglutide is compounded by licensed 503A pharmacies to the same active specifications as brand versions, but at a lower monthly cost ($189/mo start) with no insurance requirement. Brand-name products may have different availability or cost depending on your insurance, whereas PlexusDx provides transparent, flat-rate pricing.

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.